LAMP1 and neoplasm: Therefore, upregulation of LAMP1 in these contexts may serve as a marker for increased MDSC activity and a more aggressive tumor phenotype, suggesting that targeting LAMP-1 could be a potential therapeutic strategy to disrupt the immunosuppressive network established by MDSCs.